Cuesta, A. M., Albiñana, V., Gallardo-Vara, E., Recio-Poveda, L., de Rojas-P, I., de Las Heras, K. V. G., . . . Botella, L. M. (2019). The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease. Sci Rep.
Citação norma ChicagoCuesta, A. M., V. Albiñana, E. Gallardo-Vara, L. Recio-Poveda, I. de Rojas-P, K. Villar Gómez de Las Heras, D. T. Aguirre, and L. M. Botella. "The β2-adrenergic Receptor Antagonist ICI-118,551 Blocks the Constitutively Activated HIF Signalling in Hemangioblastomas From Von Hippel-Lindau Disease." Sci Rep 2019.
Citação norma MLACuesta, A. M., et al. "The β2-adrenergic Receptor Antagonist ICI-118,551 Blocks the Constitutively Activated HIF Signalling in Hemangioblastomas From Von Hippel-Lindau Disease." Sci Rep 2019.